retatrutide triple agonist gip glp-1 glucagon Retatrutide—A Game Changer in Obesity Pharmacotherapy Retatrutide, a GIP, GLP-1 and

[DOI] [PubMed] [Google Scholar] 193.Deacon C.F., Hughes T.E., Holst J.J

Drug interactions and metabolism Weight loss associated with GLP-1R use may alter drug metabolism of weight-based medications (e.g., levothyroxine, warfarin )

Moreover, this review emphasizes critical elements that are lacking in translation to unlock the full potential of GLP-1 RAs in the field of geroscience

When should the 24-hour fluid diet begin

Safety, tolerability, pharmacokinetics, and pharmacodynamics of the first-in-class GLP-1 and amylin receptor agonist, amycretin: a first-in-human, phase 1, double-blind, randomised, placebo-controlled trial

Brazg R., Xu L., Dalla Man C., Cobelli C., Thomas K., and Stein P